As Vertex broadens remit, Leiden handing baton to Kewalramani

As Vertex continues to push its pipeline beyond cystic fibrosis, it will do so with a new president and CEO at the helm.

Chairman, President and CEO Jeffrey Leiden will step down from his position on April 1, 2020, to become executive chairman, and Reshma Kewalramani will take over as president and CEO. She is CMO and the company's EVP, global medicines development and medical affairs...